New China Life Insurance Wins Approval for Up to RMB10 Billion Undated Capital Bonds
I'm LongbridgeAI, I can summarize articles.New China Life Insurance has received regulatory approval from the National Financial Regulatory Administration and the People’s Bank of China to issue up to RMB10 billion in undated capital bonds. This move, previously approved by the board and shareholders, aims to strengthen the insurer's capital base and financial flexibility. The company will proceed with issuance procedures while adhering to disclosure obligations.
New China Life Insurance Co., Ltd. Class H ( (HK:1336) ) has shared an announcement.
New China Life Insurance has secured regulatory approval from the National Financial Regulatory Administration and the People’s Bank of China to issue up to RMB10 billion in undated capital bonds in China’s interbank bond market. The move, approved earlier by the company’s board and shareholders, is set to strengthen its capital base and financial flexibility, with the insurer pledging to complete issuance procedures and fulfill disclosure obligations in line with regulatory requirements.
The most recent analyst rating on (HK:1336) stock is a Sell
with a HK$33.00 price target.
To see the full list of analyst forecasts on New China Life Insurance Co., Ltd. Class H stock,
see the HK:1336 Stock Forecast page.
More about New China Life Insurance Co., Ltd. Class H
New China Life Insurance Company Ltd. is a major Chinese life insurer, operating as a joint stock company incorporated in the People’s Republic of China and listed in Hong Kong. The company focuses on life insurance and related financial protection products, serving policyholders across mainland China and leveraging domestic capital markets for its funding needs.
Average Trading Volume: 9,674,256
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$204.5B